1. Home
  2. CYTK vs UHAL Comparison

CYTK vs UHAL Comparison

Compare CYTK & UHAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

SELL

Current Price

$54.70

Market Cap

10.7B

Sector

Health Care

ML Signal

SELL

Logo U-Haul Holding Company

UHAL

U-Haul Holding Company

SELL

Current Price

$57.75

Market Cap

9.2B

ML Signal

SELL

Company Overview

Basic Information
Metric
CYTK
UHAL
Founded
1997
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Rental/Leasing Companies
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
9.2B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CYTK
UHAL
Price
$54.70
$57.75
Analyst Decision
Buy
Analyst Count
22
0
Target Price
★ $107.39
$87.67
AVG Volume (30 Days)
★ 1.6M
129.7K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$13,368,000.00
★ $6,037,819,000.00
Revenue This Year
$79.67
$4.24
Revenue Next Year
$172.23
$5.34
P/E Ratio
★ N/A
$78.63
Revenue Growth
N/A
★ 3.59
52 Week Low
$58.25
$41.95
52 Week High
$88.31
$76.45

Technical Indicators

Market Signals
Indicator
CYTK
UHAL
Relative Strength Index (RSI) 52.28 59.56
Support Level $63.96 $54.84
Resistance Level $66.93 $62.49
Average True Range (ATR) 2.04 1.46
MACD 0.50 0.81
Stochastic Oscillator 86.71 96.80

Price Performance

Historical Comparison
CYTK
UHAL

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About UHAL U-Haul Holding Company

U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.

Share on Social Networks: